Latest news with #Treatment.comAI
Business Upturn
27-05-2025
- Business
- Business Upturn
Treatment.com AI Grants Stock Options and RSUs
By GlobeNewswire Published on May 28, 2025, 02:33 IST VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) — AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') announces that it has granted an additional 633,589 restricted share units ('RSUs') and 330,132 stock options ('Options') to continuing employees and consultants of Rocket Doctor Inc., the Company's wholly-owned subsidiary (see News Release dated April 10, 2025). The Options are each exercisable for one common share of the Company at an exercise price of C$0.50 per share for a period of three years from the grant date and vest over a one-year term. The RSUs are valid for a term of three years and vest over a period of one year from the grant date. All Options and RSUs are subject to the terms of the Company's equity plans and applicable securities law hold periods. About AI Inc. AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. Learn more at or contact [email protected] . FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO Email: [email protected] Media inquiries: [email protected] Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Hamilton Spectator
27-05-2025
- Business
- Hamilton Spectator
Treatment.com AI Grants Stock Options and RSUs
VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) — AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') announces that it has granted an additional 633,589 restricted share units ('RSUs') and 330,132 stock options ('Options') to continuing employees and consultants of Rocket Doctor Inc., the Company's wholly-owned subsidiary (see News Release dated April 10, 2025). The Options are each exercisable for one common share of the Company at an exercise price of C$0.50 per share for a period of three years from the grant date and vest over a one-year term. The RSUs are valid for a term of three years and vest over a period of one year from the grant date. All Options and RSUs are subject to the terms of the Company's equity plans and applicable securities law hold periods. About AI Inc. AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. Learn more at or contact info@ . FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO Email: ehamza@ Media inquiries: media@ Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
Yahoo
27-05-2025
- Business
- Yahoo
Treatment.com AI Grants Stock Options and RSUs
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') announces that it has granted an additional 633,589 restricted share units ('RSUs') and 330,132 stock options ('Options') to continuing employees and consultants of Rocket Doctor Inc., the Company's wholly-owned subsidiary (see News Release dated April 10, 2025). The Options are each exercisable for one common share of the Company at an exercise price of C$0.50 per share for a period of three years from the grant date and vest over a one-year term. The RSUs are valid for a term of three years and vest over a period of one year from the grant date. All Options and RSUs are subject to the terms of the Company's equity plans and applicable securities law hold periods. About AI Inc. AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. Learn more at or contact info@ FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO Email: ehamza@ Media inquiries: media@ Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Upturn
15-05-2025
- Health
- Business Upturn
Treatment.com AI and Rocket Doctor Applaud US Health Secretary RFK Jr.'s Call for Greater Investment in Telehealth and AI-Driven Diagnostic Tools
RFK Jr. calls for a 'revolution' in telehealth and AI to reduce ER visits and improve at-home care. AI and Rocket Doctor applaud the remarks, citing strong alignment with their mission. Rocket Doctor is currently empowering physicians to run their own practices in New York and California, serving Medicaid and Medicare patients in underserved communities. VANCOUVER, BC, May 15, 2025 (GLOBE NEWSWIRE) — AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') and Rocket Doctor, its wholly owned online care platform, applaud United States Secretary of Health and Human Services, Robert F. Kennedy Jr., for his remarks during the House Appropriations Committee Budget Hearing yesterday, where he championed the potential role of telehealth and artificial intelligence in improving access to care. 'We are going to dramatically revolutionize the availability of telehealth and AI so that people can avoid emergency rooms by getting treated at home,' said Secretary Kennedy Jr. 'I looked at a technology yesterday that can accurately diagnose strep throat using your telephone camera with one picture of the inside of your throat…you can prevent somebody from having to go to the emergency room, and you can get them a prescription on site.' (see: Budget Hearing – U.S. Department of Health and Human Services – 2:12:25) These comments echo Treatment and Rocket Doctor's mission, and whose virtual care technologies are already making this future a reality. Across New York and California, Rocket Doctor's platform enables physicians to start their own practices and remotely diagnose and treat Medicare and Medicaid patients using advanced AI tools and Bluetooth-enabled medical devices. This service is providing patients in cities and rural communities with accurate, in-home assessments while reducing the need for emergency care visits. 'Virtual care is the great equalizer,' said Dr. William Cherniak, CEO and Founder of Rocket Doctor. 'Whether it's using a smartphone otoscope to examine an ear infection or a bluetooth connected stethoscope to assess lungs, we're equipping doctors and patients with the tools to make timely, accurate decisions from anywhere and anytime. Secretary Kennedy's remarks validate what we've been building: a healthcare model that is accessible for all people, where care comes to you.' He added 'As a practicing ER doctor I have seen first hand the challenges of patients using much more costly emergency services, when they could have safely been managed outside the four walls of the hospital. Our system is designed to address this problem, so far helping over 4,000 patients avoid emergency care at a hospital (see ) and subsequently we won Stanford's Emergency Medicine pitch contest for the innovative approach.' To further underscore its innovation, the American Telemedicine Association (ATA) recently announced Rocket Doctor as Clinical Innovator of the Year at its Innovators Challenge. Treatment further enhances this model through its proprietary Global Library of Medicine (GLM), a comprehensive, physician-developed AI engine that supports diagnosis and care planning. The GLM can be consumed in several ways, as examples powering health chatbots and voice agents, enabling intelligent patient onboarding and triage before any provider engagement. 'AI is offering the possibility to significantly impact healthcare for the 3 Ps: the Patient, the Provider, and the Payer,' said Dr. Essam Hamza, CEO of AI. 'It increases accuracy, improves workflow efficiency, and reduces unnecessary costs. What Secretary Kennedy described isn't hypothetical, it's happening now and we're proud to be at the forefront.' Together, Treatment and Rocket Doctor are demonstrating what's possible when technology, clinical expertise, and health system innovation align, helping patients avoid ER visits, shortening diagnostic timelines, and expanding access to high-quality care. About AI Inc. AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. Learn more at or contact [email protected]. About Rocket Doctor Inc. Rocket Doctor is a technology-driven digital health platform and marketplace that is breaking down obstacles that limit access to quality, comprehensive and cost-effective healthcare. Our proprietary software equips doctors with the tools to run successful practices in virtual and hybridized in-person/virtual models of care, enabling them to provide tailored care to patients in remote communities, particularly those in rural and Northern communities across Canada and on Medicaid in the United States. Leveraging large language models, AI/ML and wireless medical devices, Rocket Doctor is bridging the healthcare divide, connecting patients to equitable and accessible virtual healthcare services regardless of age, location, or financial status. This includes patients with potentially stigmatizing conditions such as substance use, mental health and otherwise. To learn more about Rocket Doctor's platform and services, visit (Canada) or (U.S.), or contact [email protected] . FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO Email: [email protected] Media inquiries: [email protected] Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 Cautionary Statement This news release contains forward-looking statements that are based on AI's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although AI believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and AI undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Yahoo
20-02-2025
- Business
- Yahoo
Treatment.com AI and Rocket Doctor CEO's meet for a fireside chat to discuss the recently announced acquisition and the future of AI in healthcare
VANCOUVER, British Columbia, Feb. 20, 2025 (GLOBE NEWSWIRE) -- AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') is pleased to advise that further to its announcement that it has entered into a Definitive Share Purchase Agreement dated February 12, 2025 (the 'Definitive Agreement') to acquire Rocket Doctor Inc. ('Rocket Doctor'), details of which are in Treatment's Press Release dated 12th February 2025 the CEO's of AI and Rocket Doctor Inc have combined for a fireside chat to discuss in more detail the acquisition and its opportunities. They also cover the most recent Press Release dated February 19, 2025 Dr. Essam Hamza, CEO of AI and Dr. Bill Cherniak, CEO and Founder of Rocket Doctor meet with Penny Queen. They discuss their views on how Treatment and Rocket Doctor technologies can play a role in positively improving the healthcare sector and impact current inefficiencies and challenges. About AI Inc. AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. To learn more about Treatment's products and services: or email: About Rocket Doctor Inc. Rocket Doctor is a technology-driven digital health platform and marketplace that is breaking down obstacles that limit access to quality, comprehensive and cost-effective healthcare. Our proprietary software equips doctors with the tools to run successful practices in virtual and hybridized in-person/virtual models of care, enabling them to provide tailored care to patients in remote communities, particularly those in rural and Northern communities across Canada and on Medicaid in the United States. Leveraging large language models, AI/ML and wireless medical devices, Rocket Doctor is bridging the healthcare divide, connecting patients to equitable and accessible virtual healthcare services regardless of age, location, or financial status. This includes patients with potentially stigmatizing conditions such as substance use, mental health and otherwise. To learn more about Rocket Doctor's platform and services, visit (U.S.) (Canada) or email . FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEOFor media inquiries, contact: Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955Cautionary Statements This news release contains forward-looking statements that are based on AI's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. These forward-looking statements or information may relate to the consummation of Rocket Doctor's California Medicaid transaction and the expected benefits to Rocket Doctor of such transaction and other factors or information. Although believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. Future Oriented Financial Information This news release also contains future-oriented financial information and financial outlook (collectively, 'FOFI') about Rocket Doctor's forecasted revenues and gross margins from thepartnership with a California managed care plan which is subject to the same assumptions, risk factors, limitations, and qualifications as set forth in the above paragraphs. FOFI contained in this news release was made by management as of the date of this news release and was provided for the purpose of providing readers with an understanding of the importance of such transactions to Rocket Doctor's business, and are not an estimate of profitability or any other measure of financial performance. Readers are cautioned that the FOFI contained in this news release should not be used for purposes other than for which it is disclosed herein. The Company disclaims any intention or obligation to update or revise any FOFI contained in this News Release, whether as a result of new information, future events or otherwise, unless required pursuant to applicable law. FOFI contained in this news release should not be used for purposes other than for which it is disclosed herein. The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
